Related Experiment Video
Updated: Sep 4, 2025

In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing
Published on: May 5, 2023
Mutant KRAS regulates transposable element RNA and innate immunity via KRAB zinc-finger genes
Roman E Reggiardo1, Sreelakshmi Velandi Maroli2, Haley Halasz2
1Department of Biomolecular Engineering, University of California, Santa Cruz, Santa Cruz, CA 95064, USA.
Abstract:
RAS genes are the most frequently mutated oncogenes in cancer, yet the effects of oncogenic RAS signaling on the noncoding transcriptome remain unclear. We analyzed the transcriptomes of human airway and bronchial epithelial cells transformed with mutant KRAS to define the landscape of KRAS-regulated noncoding RNAs. We find that oncogenic KRAS signaling upregulates noncoding transcripts throughout the genome, many of which arise from transposable elements (TEs). These TE RNAs exhibit differential expression, are preferentially released in extracellular vesicles, and are regulated by KRAB zinc-finger (KZNF) genes, which are broadly downregulated in mutant KRAS cells and lung adenocarcinomas in vivo. Moreover, mutant KRAS induces an intrinsic IFN-stimulated gene (ISG) signature that is often seen across many different cancers. Our results indicate that mutant KRAS remodels the repetitive noncoding transcriptome, demonstrating the broad scope of intracellular and extracellular RNAs regulated by this oncogenic signaling pathway.
Insights
Oncogenic RAS signaling, common in cancer, alters noncoding RNAs, particularly those from transposable elements (TEs). Mutant KRAS remodels the transcriptome, impacting cellular and extracellular RNA, with implications for cancer progression.
Area of Science:
- Cancer Biology
- Molecular Oncology
- Transcriptomics
Background:
- RAS genes are frequently mutated oncogenes in various cancers.
- The impact of oncogenic RAS signaling on the noncoding transcriptome is not well understood.
Purpose of the Study:
- To investigate the effects of oncogenic RAS signaling on noncoding RNA.
- To define the landscape of KRAS-regulated noncoding RNAs in human airway and bronchial epithelial cells.
Main Methods:
- Analysis of transcriptomes from human airway and bronchial epithelial cells engineered with mutant KRAS.
- Investigated differential expression of transposable element (TE) RNAs.
- Examined regulation by KRAB zinc-finger (KZNF) genes and induction of IFN-stimulated gene (ISG) signatures.
Main Results:
- Oncogenic KRAS signaling upregulates noncoding transcripts, including many from TEs.
- TE RNAs show differential expression, are released in extracellular vesicles, and are regulated by downregulated KZNF genes.
- Mutant KRAS induces an IFN-stimulated gene (ISG) signature observed in many cancers.
Conclusions:
- Mutant KRAS significantly remodels the repetitive noncoding transcriptome.
- This pathway broadly regulates both intracellular and extracellular RNAs.
- Findings highlight the extensive impact of oncogenic RAS signaling on RNA regulation in cancer.
Related Concept Videos
The Ras Gene
Ras is a...
Non-LTR Retrotransposons
piRNA - Piwi-interacting RNAs
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Overview of Transposition and Recombination
LTR Retrotransposons
The internal coding region of LTR retrotransposons and their mechanism of transposition closely resembles a...

